Thistle Mary
Transactions
50
Companies
8
Filings
13
CIK
0001317917
Recent Transactions
- Award
- Award
- Award
- Award
- Award
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Award
- Award
- Award
- Disposition to Issuer
- Award
- Award
- Award
- Disposition to Issuer
- Disposition to Issuer
- Award
- Award
- Disposition to Issuer
- Award
- Award
- Award
- Award
- Award
- Award
Employee Stock Option (right to buy)
2023-06-06+100,000→ 100,000 total - Award
Employee Stock Option (right to buy)
2022-06-22+100,000→ 100,000 total - Award
Employee Stock Option (right to buy)
2022-06-22+100,000→ 100,000 total - Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Disposition to Issuer
- Award
Companies
8- $AKTS
Aktis Oncology, Inc.
Director
- $TCRT
Alaunos Therapeutics, Inc.
Director
- $CGEM
Cullinan Therapeutics, Inc.
Director
Dimension Therapeutics, Inc.
Chief Operating Officer
- $TRDA
Entrada Therapeutics, Inc.
Director
- $QTTB
Q32 Bio Inc.
Director
VIACELL INC
Sr VP & GM Reproductive Health
Vigil Neuroscience, Inc.
Director
Recent Filings
13- 4/A
Thistle Mary
Jul 21, 2026
- 4
Thistle Mary
Jun 18, 2026
- 4
Thistle Mary
Jun 16, 2026
- 4
Thistle Mary
Jun 12, 2026
- 4
Thistle Mary
Oct 27, 2025
- 4
Thistle Mary
Aug 5, 2025
- 4
Thistle Mary
Jun 12, 2025
- 4
Thistle Mary
May 23, 2025
- 4
Thistle Mary
Feb 26, 2025
- 4
Thistle Mary
Aug 9, 2024
- 4
Thistle Mary
Jun 14, 2024
- 4
Thistle Mary
Jun 7, 2024
- 4
Thistle Mary
May 7, 2024
Address
Q32 BIO INC. 830 WINTER STREET
WALTHAM, MA, 02451